MedPath

My Health Tags - To improve taking tablets for heart failure

Not Applicable
Completed
Conditions
Specialty: Cardiovascular disease, Primary sub-specialty: Heart failure
UKCRC code/ Disease: Cardiovascular/ Hypertensive diseases
Circulatory System
Heart failure
Registration Number
ISRCTN58513123
Lead Sponsor
niversity Hospitals Bristol NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Age over 18 years
2. Able to provide informed consent
3. Diagnosis of heart failure made more than one month prior to enrollment
4. On medication for heart failure including ACEi/ARB and B-blocker
5. Has 4 week supply of ACE/ARB and B blocker
6. Live in postcode areas BS1 – BS16
7. Able to read and understand instructions in English

Exclusion Criteria

1. Medication given by partner or other care-provider
2. Use of dosette box
3. History of advanced dementia
4. Planned travel away for home for more than 7 consecutive days during the study period
5. 3G and WiFi signal absent or very poor in patient’s home
6. Expected to change dose of ACEi/ARB or BB during the study period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of ACE/ARB and Beta Blocker heart failure tablets taken during the study period, calculated from the pill count taken by the research nurse at baseline, 4, and 8 weeks
Secondary Outcome Measures
NameTimeMethod
<br> 1. Mean difference between groups, in the proportion of patients with chronic heart failure taking >80% of prescribed pills (ACEi/ARB and BB) over a four-week period<br> 2. Mean difference between groups in change in MMAS-8 scores measured at baseline, 4, and 8 weeks between baseline and the end of the treatment block<br> 3. Mean difference between groups in change in urine metabolite numbers, measured at baseline, 2, 4, 6 and 8 weeks between baseline and the end of the treatment block<br>
© Copyright 2025. All Rights Reserved by MedPath